{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Neurocrine Biosciences, Inc."},"Symbol":{"label":"Symbol","value":"NBIX"},"Address":{"label":"Address","value":"12780 EL CAMINO REAL, SAN DIEGO, California, 92130, United States"},"Phone":{"label":"Phone","value":"+1 858 617-7600"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome."},"CompanyUrl":{"label":"Company Url","value":"https://www.neurocrine.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Bill Wilson","title":"Vice President-Information Technology & Operations"},{"name":"Dimitri E. Grigoriadis","title":"Chief Research Officer"},{"name":"Eiry W. Roberts","title":"Chief Medical Officer"},{"name":"Jude Onyia","title":"Chief Scientific Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}